Proprietary Thinking for the Intelligent Investor

Search for:

Search
- Home
- About
- Propthink Premium
- Content
- SPA Database
- Recent Research

Insights
Research
Interviews
Education

Search Results for QLTI

A Roundup of Our Top Stories in Healthcare from the Week

Recap - It looked briefly at mid-week like the biotech sector’s correction might be a comical 48-hour event, but investors are in a tizzy over the emerging … Continue Reading

Read now

Insights

Alexion’s Beat, Raise, and Improved Tax Status Has Broader Implications

Insights - With the release of its full-year ’13 and Q4 financials on Thursday, Alexion Pharmaceuticals (ALXN) beat on both earnings and revenue, now guiding for 2014 … Continue Reading

Read now

Insights

Biotech Recap: Our Top Stories from the Week

Insights - Last week we introduced a new look for PropThink.com and launched a more affordable option for PropThink readers interested in exploring our Premium content. Not to worry, we’ll still … Continue Reading

Read now

Research

Canadian Acquisitions: QLT Inc. Fits the Trend

Research - It seems QLT Inc. may be on the block after a press release on Wednesday evening indicated the company has engaged Credit Suisse as a … Continue Reading

Read now

Newer posts →

Get The Professional Edge

Try Risk Free

Follow Propthink

Disclaimer & Terms of Service - Privacy Policy

Recent Press

Recent Press:

PropThink

PropThink is an intelligence service tailored for the healthcare and life sciences sectors.

Join Us

PropThink Premium
About
Disclaimer & Terms of Service

Browse

Insights
Research
Interviews
Education

We Are Reserving Your Spot

Sign-In To Propthink

Please Enter Your Email.

Please Enter A Password.

Forgot Your Password?

Incorrect Username And/Or Password

Please Complete Registration

Completing the following survey to access content

Register for FREE to access

Don't worry - this will only take a minute

Please Enter Your First Name.

Please Enter Your Last Name.

Please Enter A Valid Email.

Please Enter A Valid Password. Must Be At Least 8 Characters .

I agree to the terms and conditions

To continue with registration, you must agree to our terms of service

Already A Member? Sign In

Which Best Describes You?

Investor

Banker

Media

Other

Which Best Represents You?

Analyst

Executive

Investor Relations

SEC Attorney

Auditor

Physician

Consultant

None

Which Opportunities Interest You?
(Select All That Apply)

Please Select At Least One Interest From Each Row

Micro Cap

Small Cap

Mid/Large Cap

Biotech & Pharma

Medical Devices

Healthcare Services

Which Opportunities Interest You?
(Select All That Apply)

Please Select At Least One Interest

Investment Ideas

Trading Ideas

Healthcare News

Clinical Trials

Biz Dev

Networking

Which Opportunities Interest You?
(Select All That Apply)

Please Select At Least One Interest From Each Row

Micro Cap

Small Cap

Mid/Large Cap

Biotech & Pharma

Medical Devices

Healthcare Services

Equities

Debt

Private Placements

Which Opportunities Interest You?
(Select All That Apply)

Please Select At Least One Interest

Healthcare

Biotech

Technology

Investing

Leadership

Interviews

Conference Calls

Podcast/Webcast

Exclusive Features

News Articles

Are You Accredited

A person who either:

Earned income that exceeded $200,000 (or $300,000 together with a spouse) in each of the prior two years, and reasonably expects the same for the current year,

Has a net worth over $1 million, either alone or together with a spouse (excluding the value of the person’s primary residence).

I manage or have discretionary assets of

< $5 Million

$5-$30 Million

> $30 Million

Please Select Your Asset Size

Registration Complete

You're all done! We've sent you a confirmation email that includes a verification link. To access the page you're interested in, check your email inbox(including spam folder) and click the verification link.

Four

Five

0% Complete

Please Confirm Your Email!

We've sent you a confirmation email that includes a verification link. To access the page you're interested in, check your email inbox and click the verification link.

If you cannot find it, be sure to check you "SPAM" or click "RESEND EMAIL" below.

Forgot your password?

Enter the email address associated with your account and we'll send you details on how to reset your password.

Reset Link Emailed

A email with details on resetting your password has been sent.

Your question is submitted. Our moderators are reviewing the question and will approve it shortly.

Downgrade Account

You are not logged in

Join now, it's free:

Email:

Email already registered. Forgot Password?

Password:

Passwords must match.

Password must be a minimum of 8 characters.

Confirm Password:

Solve the following: 6 + 4 =

Please answer the security question correctly.

I agree to the Terms of Use and Privacy Policy

Member sign-in:

Password or Email is Incorrect. Forgot Password?

Error updating account.

Email:

Password: Forgot Password?

RESTRICTED ACCESS. PROPTHINK PREMIUM.

PROPTHINK PREMIUM.

Professional Edge

Actionable Trading Ideas

Proven Returns

314 ideas with avg 54% return over 5+ years

Proprietary Access

Access to Professional Research Team

Try Risk-Free

Learn More

Already A Member?Login

Try Risk Free

Professional Edge

Actionable Trading Ideas

Proven Returns

314 ideas with avg 54% return over 5+ years

Proprietary Access

Access to Professional Research Team

Learn More

Already A Member?Login

Forgot your password?

Enter the email address associated with your account and we'll send you details shortly.

You're trying to access some of PropThink's Members-Only Content.

You can sign up for a FREE PropThink membership, unlocking significantly more of PropThink’s features, by clicking here. All it takes is an email address.

Better yet, try PropThink Premium. Click here to read more about the features of PropThink Premium, and get 50% off your first month!

Get 50% off your first month